Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · IEX Real-Time Price · USD
3.310
+0.190 (6.09%)
Jul 19, 2024, 12:00 AM EDT - Market open
Cyclerion Therapeutics Employees
Cyclerion Therapeutics had 1 employees as of December 31, 2023. The number of employees decreased by 15 or -93.75% compared to the previous year.
Employees
1
Change (1Y)
-15
Growth (1Y)
-93.75%
Revenue / Employee
n/a
Profits / Employee
$149,000
Market Cap
8.97M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Syra Health | 162 |
Zhongchao | 142 |
Molecular Templates | 62 |
Organovo Holdings | 20 |
NLS Pharmaceutics AG | 7 |
Nexalin Technology | 6 |
Mangoceuticals | 3 |
Silo Pharma | 3 |
CYCN News
- 8 months ago - Cyclerion Appoints Regina Graul, Ph.D., as President - GlobeNewsWire
- 8 months ago - Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator - GlobeNewsWire
- 1 year ago - Tisento Launches with $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion Assets - GlobeNewsWire
- 1 year ago - Cyclerion Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 1 year ago - Cyclerion Announces Reverse Stock Split - GlobeNewsWire
- 1 year ago - Cyclerion Announces Definitive Agreement for Zagociguat and CY3018 - GlobeNewsWire
- 1 year ago - Cyclerion Announces Corporate Updates and Q1 2023 Financial Results - GlobeNewsWire
- 1 year ago - Cyclerion Therapeutics Enters into Exclusive Negotiation Period and Binding Equity Investment Agreement - GlobeNewsWire